title: Hyperselective intra-arterial preoperative chemotherapy in patients with squamous cell carcinoma of the oral cavity: preliminary results.
abstract: OBJECTIVE
  To investigate radiological response and findings after Intra Arterial Chemotherapy (IAC) for patients with Squamous Cell Carcinoma (SCC) of the oral cavity.
  
  
  METHODS
  Patients received 1-2 cycles of IAC. Radiological assessment was performed on day 7 and day 21 after each cycle using CT scan and MRI.
  
  
  RESULTS
  Six patients (median age: 52, ranging 46-60; male/female: 5/1) received 10 cycles (4 patients received 2 cycles). Primary tumors were floor of the mouth (4 patients) and oral tongue (2 patients). TNM classification was T2N0-2b in 3 patients and T4N0-1 in 3 patients. All patients had good locoregional/systemic tolerance and 3 showed clinical objective response (OR). Four patients were evaluable on both CT and MRI, 1 patient on MRI only and 1 patient did not tolerate imaging. Three patients showed OR both on CT and MRI, 1 patient showed stable disease (SD) on CT and OR on MRI and 1 patient showed SD on MRI. Contrast-enhancement of hemiperfused tongue was reported in all evaluable patients. Two patients presented intratumoral necrosis and 5 patients displayed local edema (MRI). One patient had modification of the sternocleidomastoid muscle after IAC.
  
  
  CONCLUSIONS
  Radiological modifications were observed in the infused area and correlated well with clinical response. This study is ongoing.
authors.affiliation: Institut Gustave-Roussy, 39 avenue Camille Desmoulins, 94805 Villejuif Cedex, France. bidault@igr.fr
authors.forename: F
authors.initials: F
authors.lastname: Bidault
authors.forename: S
authors.initials: S
authors.lastname: Faivre
authors.forename: V
authors.initials: V
authors.lastname: Kuoch
authors.forename: P
authors.initials: P
authors.lastname: Petrow
authors.forename: S
authors.initials: S
authors.lastname: Temam
authors.forename: T
authors.initials: T
authors.lastname: De Baere
authors.forename: F
authors.initials: F
authors.lastname: Janot
authors.forename: O
authors.initials: O
authors.lastname: Casiraghi
authors.forename: B
authors.initials: B
authors.lastname: Luboinski
authors.forename: A
authors.initials: A
authors.lastname: Roche
authors.forename: R
authors.initials: R
authors.lastname: Sigal
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis* / Q000188:drug therapy* / Q000601:surgery; D002945:Cisplatin / Q000008:administration & dosage*; D000077143:Docetaxel; D005260:Female; D006801:Humans; D007261:Infusions, Intra-Arterial; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000175:diagnosis* / Q000188:drug therapy* / Q000601:surgery; D043823:Taxoids / Q000008:administration & dosage*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D043823:Taxoids; D000077143:Docetaxel; D002945:Cisplatin